Journal of Organometallic Chemistry p. 363 - 367 (2019)
Update date:2022-08-18
Topics:
Tang, Meng
Zhu, Senqiang
Liu, Rui
Wang, Jia
Zhang, Zheng
Zhu, Hongjun
A series of cationic heteroleptic Ir(III) complexes with different N-heterocycle groups (N-phenothiazinyl, N-indolyl, N-carbazolyl, 3,6-di-tert-butyl-N-carbazolyl) were synthesized and characterized. The photophysical properties of these complexes were systematically investigated. All complexes exhibit strong 1π-π? absorption bands in the UV region and broad 1MLCT absorption bands in the visible region. In addition, these complexes exhibit weak absorption after 500 nm, which could be attributed to 3π,π?/3CT transition. All complexes exhibit broad and structureless emission bands from 568 nm to 627 nm at room temperature, which are originated from 3MLCT/3LLCT excited states. The electron donating substituents attached on the 2-phenylpyridine ligands cause a pronounced red-shift of the emission band. Except 1d, all complexes show strong triplet transient absorptions from UV to visible region, which were assigned to the 3MLCT/3π,π? excited state. In addition, complexes 1a-1c all exhibit reverse saturable absorption (RSA) at 532 nm, which follows the trend of 1a>1b > 1c. The photophysical properties of these Ir(III) complexes can be influenced drastically by the substituents on 2-phenylpyridine ligands, which would be useful for rational design of optical functional materials.
View MoreShandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
website:http://www.acrospharmatech.com
Contact:+1-3234804688
Address:Flat/RM 1502,Easey Commercial building 253-261 Hennessy Road,Wanchai,HongKong
Huzhou City Linghu Xinwang Chemical Co.,Ltd.
Contact:86-572-3948695/3945236
Address:huzhou
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Wuhan Silworld Chemical Co.,Ltd
website:http://www.silworldchemical.com
Contact:+86-27-85613400
Address:No.198 jiangjun Road, Wuhan,China 430033
Doi:10.1021/jf00056a026
(1995)Doi:10.1016/S0040-4039(98)02650-1
(1999)Doi:10.1021/ja01327a063
(1934)Doi:10.1248/cpb.c17-00564
(2017)Doi:10.1021/acsmedchemlett.0c00533
(2021)Doi:10.1039/c8ob01438h
(2018)